Spectra Pharmaceutical Services Inc said current clinical study proposed dry eye drug Tretinoin produced encouraging result based preliminary indication .
The compnay said test conducted submission Food Drug Administration drug trade name Lacramore .
Spectra said earlier study showing dramatic improvement isolated case still occurred .
However , overall evaluation large number patient dry eye syndrome demonstrate consistantly beneficial result , added .
Spectra said continue current study , time undertaking review feasability proposed product Spectra , development stage company , also said introduced first proprietary product , hyo-allergenic noniirritating cleanser cleaning eyelid eyelash .
The company said also begun marketing line ophthalmic drug .
Reuter & # 3 ; 